Allevion Medical Gains FDA 510(k) for Vantage System
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
BOCA RATON, Fla., April 1, 2026 Allevion Medicalâ„¢ announced that the U.S. Food and Drug Administration (FDA) has granted...
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
SAN JOSE, Calif., March 12, 2026 PROCEPT BioRobotics has announced the international launch of its HYDROS® Robotic System, a...
AMSTERDAM, the Netherlands, March 3, 2026 The SHERPA research consortium, coordinated by Royal Philips, has initiated seven clinical studies...
February 24, 2026 – Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
February 24, 2026 – Redwood City, California, USA The U.S. Food and Drug Administration (FDA) has granted regulatory clearance...
September 17, 2025 — The Hague, The Netherlands Amber Implants has received FDA 510(k) clearance for its VCFix® Spinal...
